Why is everyone talking about Mineral Resources, A2 Milk and Pro Medicus shares on Thursday?

A2 Milk, Mineral Resources, and Pro Medicus shares are making waves today.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Mineral Resources Ltd (ASX: MIN), A2 Milk Co Ltd (ASX: A2M), and Pro Medicus Ltd (ASX: PME) shares are turning heads today.

As we head into the Thursday lunch hour, two of the ASX 200 heavyweights are charging ahead of the 0.2% losses posted by the S&P/ASX 200 Index (ASX: XJO) at this time, while one is trailing that performance.

Here's what's grabbing ASX investor interest on Thursday.

An old-fashioned news boy stands on a stool and yells through a microphone in an open field.

Image source: Getty Images

Pro Medicus shares leap on AI news

Pro Medicus shares are up 2.5% at the time of writing, swapping hands for $183.40 each.

This outperformance follows an announcement from the ASX 200 health imaging company on how it is expanding its AI-driven cardiology solutions.

In the latest move, Pro Medicus has signed binding heads of agreement with AI and medical technology company Echo IQ Ltd (ASX: EIQ).

The deal would see Pro Medicus take an initial $10 million stake in Echo IQ. A further $10 million investment is contingent on Echo securing US FDA approval for its EchoSolv HF product.

Commenting on the deal that's helping boost Pro Medicus shares today, CEO Sam Hupert said:

In addition to providing financial backing, we are looking to offer our Visage 7 Cardiology customers the option of Echo IQ's technology.

This is in line with our AI strategy of offering a curated suite of algorithms that will be a mixture of algorithms created by us, those created in conjunction with our clinical partners and third party algorithms such as Echo-IQ.

A2 Milk shares surge on NZ$300 million special dividend

A2 Milk shares are also catching investor attention today, and outperforming, after the board declared a NZ$300 million fully-franked special dividend.

The welcome passive income boost follows the recent Chinese approval to transition product registrations to A2 Milk-branded infant formula.

And it sees shares in the infant formula company up 4.1% today, trading for $7.13 each.

Breaking that NZ$300 million dividend payout down, it equates to 41.36 New Zealand cents per share (33.90 Aussie cents at current exchange rates).

If you want to bag the special A2 Milk dividend, you'll need to own shares by market close on 7 July. A2 Milk shares trade ex-dividend on 8 July.

Commenting on the special dividend payout boosting A2 Milk shares today, chair Pip Greenwood, said:

With the necessary China regulatory approvals now in place, the board is pleased to declare a $300 million special dividend. This reflects our commitment to delivering shareholder returns while maintaining disciplined capital management.

Which brings us to…

Mineral Resources shares sink on mine closure

Joining A2 Milk and Pro Medicus shares in grabbing headlines today is lithium miner and diversified resources producer Mineral Resources.

However, Mineral Resources shares are underperforming today, down 2.9% at $63.93 apiece.

This comes amid news that the ASX 200 mining stock is placing its Western Australia-based Lucky Bay Garnet Project into care and maintenance at the end of the month.

Mineral Resource noted:

The mine's financial performance has been materially impacted by ongoing conflict in the Middle East, a region representing a significant proportion of Lucky Bay's sales.

Combined with materially higher diesel and shipping costs, a strategic review of Lucky Bay has determined it is in the best interests of the company and its shareholders to cease operations and transition the project into care and maintenance, effective 1 July 2026.

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has recommended Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

Man drawing an upward line on a bar graph symbolising a rising share price.
Share Gainers

Why A2 Milk, EchoIQ, Lendlease, and Qantas shares are racing higher today

These shares are having a strong session on Thursday. What's going on?

Read more »

A man in a business suit holds his hand up to his mouth as though sharing a secret and gives a sly grin.
Broker Notes

Top broker just put a buy rating on this ASX share with 6.7% yield

Bell Potter has good things to say about this stock.

Read more »

Two brokers pointing and analysing a share price.
Broker Notes

1 ASX share to accumulate, one to hold, and one to sell

Morgans has given its verdict on the shares. Let's see what it is recommending.

Read more »

A smiling businessman in the city looks at his phone and punches the air in celebration of good news.
Broker Notes

Forget PLS shares, this US-focused ASX lithium share could rise 100%+

Bell Potter sees potential for this lithium stock to more than double in value.

Read more »

Contented looking man leans back in his chair at his desk and smiles.
Share Market News

5 things to watch on the ASX 200 on Thursday

Here's what to watch on the local market today.

Read more »

Ten happy friends leaping in the air outdoors.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a happy hump day for ASX investors.

Read more »

colleagues on a lunch break looking at iPhone
Broker Notes

Top brokers name 3 ASX shares to buy now

Here's what brokers are recommending as buys this week.

Read more »

Logistic workers sitting amid pallets and stock in a warehouse.
Broker Notes

Brambles shares: Buy, hold or sell?

A leading analyst provides his forecast for Brambles' rebounding share price.

Read more »